Linklaters has advised AptarGroup, Inc. (NYSE:ATR) on its entry into exclusive negotiations with respect to a potential acquisition of all outstanding shares of Voluntis S.A. (ENXTPA:ALVTX). This acquisition would complement Aptar's existing digital health portfolio of connected devices by adding digital therapeutic solutions and broadening its digital health services across multiple chronic conditions and diseases. Signature of the final acquisition agreement for a block of approximately 64% of Voluntis' share capital would occur following completion of the consultation procedure of the employee representative bodies of Voluntis.

The completion of the transfer of the block of shares would be subject to customary conditions and notably the approval of the French Ministry of Economy under the foreign investment clearance regulations. The acquisition of the controlling interest will be followed by a simplified tender offer for the remaining outstanding Voluntis shares.